U.S. market Closed. Opens in 5 hours 49 minutes

BBLGW | Bone Biologics Corporation Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of RevenueN/AN/AN/AN/A50.00N/AN/AN/AN/AN/A
Gross ProfitN/AN/AN/AN/A-50.00N/AN/AN/AN/AN/A
Operating Expenses9.43M3.67M1.10M825.01K2.45M2.79M2.63M17.85M12.00M3.01M
Selling, General & Admin2.52M2.09M1.02M484.34K1.35M2.69M3.82M6.25M8.33M1.51M
Research & Development6.91M1.58M82.04K340.67K1.10M104.49K-1.19M11.60M3.67M623.52K
Other Operating Expenses0N/AN/AN/AN/A104.49KN/AN/AN/A877.78K
Operating Income-9.43M-3.67M-1.10M-825.01K-2.45M-2.79M-2.63M-17.85M-12.00M-3.01M
Other Expenses / Income479.57K2.18M-507.61K-998.08K-975.77K-408.29K-4.42M-3.18M-1.87M-1.41M
Before Tax Income-8.95M-1.48M-1.61M-1.82M-3.42M-4.43M-7.05M-21.03M-13.87M-4.42M
Income Tax Expenses-9.43K-2.18M1.60K1.60K1.60K1.73K1.60K2.24K8.84K1.60K
Net Income-8.95M695.93K-1.61M-1.82M-3.42M-4.43M-7.05M-21.03M-13.88M-4.42M
Interest ExpensesN/A-2.18M805.11K998.08K-975.77K1.23M4.42M3.17M1.87M1.40M
Basic Shares Outstanding263.00K47.60K18.92K12.13K12.15K67.01KN/AN/AN/AN/A
Diluted Shares Outstanding263.14K47.60K18.92K12.13K12.15K67.01KN/AN/AN/AN/A
EBITDA479.57K-4.40M-1.10M-825.01K-2.45M-2.38M-2.63M-17.85M-11.99M-3.02M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-8.96M-3.67M-803.98K-825.01K-4.40M-3.20M-2.63M-17.85M-12.00M-3.02M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙